Experiences of DPYD Testing
22/02/2022
Genomic Medicine Service Alliance want to engage with cancer patients who started chemotherapy treatment since November 2020 to listen to your experience of DPYD testing.
DPD testing identifies patients at higher risk of an adverse reaction to the most used chemotherapy treatments. The two most used chemotherapy treatments are either 5-FU (5-fluorouracil) or capecitabine, so if you started chemotherapy treatment after November 2020, then you will have been DYPD tested, as part of your consent to treatment.
Testing helps to identify patients who can be treated more safely with a lower drug dose and is routine practice.
If you received treatment before November 2020 then you are not DPYD tested.
They would love to hear from you so if you would like to share your thoughts and opinions, please contact the NHS North West Genomic Medicine Service Alliance by email in the first instance, to [email protected] by Friday 11th March 2022.
Recent
NHS Cheshire And Merseyside First Recipient Of New UK-Wide Social Value Award
NHS Cheshire and Merseyside, integrated care board for the region, has become the first organisation in the UK to receive a new award for social value in health. The Social Value Quality Mark: Health Award launched in November 2023, through a partnership with the Social Value Quality Mark CIC and...
Patients Urged To Order Repeat Prescriptions Ahead of Christmas
Patients across Cheshire and Merseyside are being asked to plan ahead this Christmas by checking their regular medications and ordering any repeat prescriptions they might need early - using the NHS App. The NHS is advising that any repeat prescriptions should be ordered by Friday 15th December to...